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http://www.biomedcentral.com/1471-2458/14/983RESEARCH ARTICLE Open AccessDramatic escalation in metabolic syndrome and
cardiovascular risk in a Chinese population
experiencing rapid economic development
Xiang Qian Lao1,2, Wen Jun Ma3, Tanja Sobko4, Yong Hui Zhang5*, Yan Jun Xu5, Xiao Jun Xu5, Dong Mei Yu6,
Shao Ping Nie5, Qiu Mao Cai5, Xiao Lin Wei1, Liang Xia5 and Martin Chi-sang Wong1Abstract
Background: Metabolic syndrome (MetSyn) increases the incidence of cardiovascular disease. Information on changes
in prevalence of MetSyn in developing countries is limited. This study aims to compare MetSyn prevalence and its
associated vascular risk over the period between 2002 and 2010 in a population which has had the world’s fastest
economic development over the past three decades.
Methods: Two health surveys were conducted by using the multistage cluster random sampling method in a Chinese
population of 85 million in southern China. The participants received a full medical check-up, including measurement
of blood pressure (BP), obesity indices, fasting lipids and glucose levels. Data describing socio-economic status
and lifestyle factors were also collected through interview. Metabolic syndrome was defined in accordance with
the International Diabetes Federation criteria.
Results: A total of 3,561 participants from Survey 2010 were included in the data analysis. Women had a significantly
higher prevalence of MetSyn than men. Comparison between the two surveys shows that age-standardized prevalence
of MetSyn increased fourfold (from 5.4% in 2002 to 21.3% in 2010) in those ≧ 20 years. Among the MetSyn
components, prevalence of hyperglycaemia has increased most (from 9.1% to 53.1%). The age-standardized
prevalence of central obesity, hypertension, hypertriglyceridaemia and low HDL-cholesterol increased from
13.5% to 25.4%, from 23.6% to 40.8%, from 12.1% to 17.4% and from 32.1% to 71.1%, respectively. Differences
between rural and urban residents in the prevalence in MetSyn and its components narrowed in 2010.
Conclusions: Cardiovascular risk escalated dramatically in this population between 2002 and 2010. The escalation may
relate to the rapid economic development, which led to accelerating changes in nutrition, lifestyle, and socio-economic
status. Our findings suggest that health transition in rapidly developing second- and third-world countries may be much
faster than what has been observed in Western countries.
Keywords: Metabolic syndrome, Cardiovascular risk, Trend, Economic development, ChineseBackground
Cardiovascular disease is the leading cause of mortality
both in China and worldwide [1,2]. A constellation of
cardiovascular risk factors consisting of abdominal obesity,
hypertension, elevated fasting glucose level and dislipidemia
defines the metabolic syndrome (MetSyn) [3]. It is esti-
mated that around 38% of adults in the U.S.A. [4], and at* Correspondence: zyh@cdcp.org.cn
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unless otherwise stated.least 25% of the adult in Europe suffer from MetSyn [5-7].
A MetSyn epidemic is also emerging in certain developing
countries in Asia, Latin America, and parts of Africa [8-10],
where it has become a serious public health problem. The
emerging MetSyn epidemic in developing countries is
thought to be related to rapid industrialization and
urbanization [11]. However, information on the develop-
ment of the epidemic and the growth rate of MetSyn in
developing countries experiencing rapid economic devel-
opment is limited.. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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http://www.biomedcentral.com/1471-2458/14/983China is the world’s largest developing country and along
with rapid economic growth and urbanization it is experi-
encing an epidemic of cardiovascular disease. Previous
studies have shown that MetSyn is generally prevalent
in the Chinese population. However, the degree of preva-
lence varies across the different regions of China because
of marked differences in demographic characteristics, cul-
tural behavior, and lifestyle habits [12-16]. Furthermore,
despite the fastest GDP in the world in the past three
decades, there is little information on the growth rate of
MetSyn in Chinese. Guangdong is a province in southern
China with a population of 85 million [17]. During the past
three decades, Guangdong experienced an average annual
increase of 13.6% in GDP, the largest of all China’s 34 prov-
inces and autonomous regions [18]. Guangdong therefore
provides a unique opportunity to observe changes in
MetSyn prevalence representing a rapid epidemiological
transition resulting from industrialization and urbanization.
Results we previously published show that MetSyn was
already prevalent in 2002 [19]. To elucidate the present
situation, and to observe changes in MetSyn as well as indi-
vidual risk factors in this rapidly developing society, we
compared data from the 2002 and 2010 editions of the
Guangdong Health Survey. Such comparisons can be
valuable for physicians and policy-makers charged with
developing prevention and intervention programs for
populations undergoing rapid economic development
and urbanization.
Methods
Approvals were obtained from the Ethics Committee of
the China Center for Disease Control, and the Ethics
Committee of the Guangdong Provincial Center for Disease
Control and Prevention. A total of four standardized Health
Surveys were conducted between 2002 and 2010 [20]. The
prevalence of MetSyn in 2002 has been previously reported
[19]. No blood samples were collected in 2004 and 2007, so
it was not possible to calculate the prevalence of MetSyn
for these two years. Data for the 2010 survey were collected
from October to December. Blood samples were collected
from a subsample of 3600 residents; details of the sampling
method have been described elsewhere [21].
A central survey site was set up in each selected cluster.
Health examinations and interviews of participants were
conducted on-site following standard protocols by physi-
cians who received training specifically for the 2010 survey.
All participants gave written informed consent prior to the
survey. The questionnaire collected a wide range of infor-
mation about demographic, lifestyle and family characteris-
tics as well as personal disease histories.
Weight and height measurements were taken with partic-
ipants wearing light indoor clothing and no shoes. All these
measures were taken in the morning before breakfast.
Waist circumference was measured horizontally around thenarrowest circumference between the ribs and the iliac
crest. Body mass index (BMI) was defined as weight in kilo-
grams divided by height in square meters.
BP measurement was in accordance with the 1999 World
Health Organization/International Society of Hypertension
guidelines on hypertension [22]. Participants were required
to rest for at least five minutes in a seated position before
measurement. Three BP measurements, one minute apart,
were taken on the right arm with the participant seated.
The average of the last two readings was used for analysis.
Venous blood samples were drawn in the morning after
an overnight fast using vacutainer tubes. Fasting plasma
glucose (FPG) was measured by a spectrophotometer 721/
722 with the glucose oxidase method. Total cholesterol,
triglyceride and HDL-cholesterol were determined using a
Hitachi 7060 Automatic Chemical Analyzer at the CDC
laboratory. Methodology of the above blood sample mea-
surements are the same as the survey in 2002 [18].
The International Diabetes Federation (IDF) criteria were
used to define MetSyn because this definition takes account
of ethnic difference in waist circumference (also called cen-
tral obesity) [23]. According to the IDF criteria, participants
are classified as having MetSyn if they have central obesity
(waist circumference of ≧ 90 cm for men and of ≧ 80 cm
for women) plus any other two abnormalities from the four
shown immediately below:
1) Hypertension: systolic blood pressure ≧ 130 mmHg,
or diastolic blood pressure ≧ 85 mmHg, or treatment
of previously diagnosed hypertension;
2) Hypertriglyceridemia: ≧ 1.7 mmol/l of triglyceride or
specific medical treatment for this lipid abnormality;
3) Hypo-HDL-cholesterol: < 1.03 mmol/l of HDL-
cholesterol for men or of < 1.29 mmol/l for women;
and
4) Raised fasting glucose: overnight ≧ 5.6 mmol/l of
plasma glucose, or previously diagnosed diabetes.
To allow comparison with the prevalence of MetSyn
in 2002 [19], we included for analysis only participants
aged ≧ 20 years in the present analysis. This left us with
3,561 participants. All data analyses were performed using
SAS software, version 9.2 (SAS Institute, Cary, NC, U.S.A.).
As in our previous studies [19-21,24,25], we incorporated
the survey design parameters including weighting, stratum
and cluster, into all the analyses. The weighting was derived
from provincial 2000 census data and associated adminis-
trative data. Age-standardized prevalence was calculated
based on the year 2000 census population by using age
groups of 20–39 years, 40–59 years, and 60– years. Data
were presented separately for comparison in different sex
and urban/rural area. Urban and rural area can be used
as a proxy for socio-economic status in China due to the
sharp divide between urban and rural areas in income,
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as housing, sanitation, and other dimensions of welfare
[26,27]. The classification of urban and rural areas was
defined in the early 1990s by Chinese central government
based on their level of economic development of the time
[28]. Two sided p values of less than 0.05 were considered
to be statistically significant. 95% confidence intervals
were calculated and presented in the present study.
Results
The mean age of the population aged 20 years or above
was 50.4 (42.6, 58.1) years. Urban men had a lower smok-
ing prevalence than rural men, whereas rural women had
a higher prevalence than urban women. Men had higherTable 1 Anthropometric, blood pressure and plasma biochem
above by sex and urban/rural residence in 2010
Age (years) Urban
Rural
p
Body mass index (kg/m2) Urban
Rural
p
Waist circumference (cm) Urban
Rural
p
Systolic blood pressure (mmHg) Urban
Rural
p
Diastolic blood pressure (mmHg) Urban
Rural
p
Total cholesterol (mmol/L) Urban
Rural
p
HDL-cholesterol (mmol/L) Urban
Rural
p
Triglyceride (mmol/L) Urban
Rural
p
Fasting glucose (mmol/L) Urban
Rural
p
Education (less than primary school education, %) Urban
Rural
p
Values were presented in mean (95% CI) for continuous variables and prevalence (9education levels, more tobacco and alcohol consumption,
higher systolic BP, diastolic BP and triglyceride levels, and
lower HDL-cholesterol levels than women. The anthropo-
metric, blood pressure and plasma biochemical character-
istics of the population stratified by sex and urban/rural
residence are presented in Table 1.
The overall prevalence of MetSyn in this population was
24.5%. When compared the differences between urban and
rural residents, there were no significant differences in the
prevalence of MetSyn as well as the individual components
except for hypertriglyceridaemia. Men had a lower preva-
lence of MetSyn and central obesity, but a higher
prevalence of hypertension and hypertriglyceridaemia
and Hyperglycaemia than women. The prevalence ofical characteristics in the population aged 20 years or
Men (1,604) Women(1,957) p
52.3 (43.9, 60.6) 50.7 (43.4, 60.6) 0.024
50.4 (36.4, 64.4) 49.2 (39.0, 59.5) 0.28
0.66 0.65
23.4 (21.3, 25.6) 23.3 (21.4, 25.2) 0.31
22.9 (22.8, 22.9) 22.5 (21.2, 23.8) 0.34
0.36 0.28
82.6 (75.4, 89.7) 78.0 (74.8, 81.3) 0.019
81.6 (77.6, 85.7) 78.2 (66.8, 89.7) 0.14
0.68 0.95
135 (133, 138) 128 (127, 129) 0.0025
133 (122, 144) 128 (119 137) 0.0015
0.46 0.96
82 (79, 86) 80 (79, 80) 0.024
81 (78, 85) 79 (77, 80) 0.009
0.63 0.51
4.25 (4.01, 4.49) 4.50 (4.09, 4.50) 0.11
4.16 (4.07, 4.24) 4.17 (4.02, 4.32) 0.84
0.72 0.41
0.97 (0.77, 1.17) 1.15 (1.01, 1.28) 0.014
0.99 (0.95, 1.02) 1.08 (1.02, 1.13) < 0.001
0.83 0.44
1.48 (1.29, 1.67) 1.19 (0.74, 1.64) 0.030
1.45 (1.20, 1.71) 1.16 (1.00, 1.32) 0.056
0.85 0.86
6.41 (5.55, 7.27) 6.27 (5.72, 6.81) 0.16
5.75 (5.04, 6.47) 5.78 (4.66, 6.90) 0.79
0.085 0.19
11.0 (0.0, 23.7) 19.0 (0.0, 40.9) < 0.001
9.0 (0.0, 18.5) 30.7 (26.1, 35.3) < 0.001
0.59 0.058
5% CI) for categorical variables.
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rural residence are presented in Table 2.
The prevalence of MetSyn increased significantly with
age. The prevalence of MetSyn in the population stratified
by age group, sex and urban/rural residenceare presented
in Table 3.
The age-standardized prevalence of MetSyn increased
fourfold (from 5.4% in 2002 to 21.3% in 2010). Among the
components, the greatest increase was for hyperglycaemia,
from 9.1% to 53.1%, but dramatic increases were also found
for central obesity, hypertension, low HDL-cholesterol and
hypertriglyceridaemia. The comparison between 2002 and
2010 of the age-standardized prevalence rates of MetSyn
and its components are presented in Table 4.
Discussion
Comparisons of the prevalence of MetSyn across popula-
tions are difficult because of differences in the definition
of MetSyn by international authorities. Many organiza-
tions have tried to develop a unifying definition since
Reaven raised the term “syndrome X” in 1988. The def-
initions frequently used in research include the criteria
proposed by World Health Organization (WHO), the
European Group for the Study of Insulin Resistance (EGIR),
the US National Cholesterol Education Program Adult
Treatment Panel III (NCEP ATP III), the American Associ-
ation of Clinical Endocrinologists (AACE), the InternationalTable 2 Prevalence (95% CI) of individual components of the
Federation guidelines in southern Chinese aged 20 years or a
Central obesity Urban 21
Rural 17
p
Hypertension Urban 61
Rural 57
p
Hypertriglyceridaemia Urban 27
Rural 22
p
Low HDL-cholesterol Urban 64
Rural 62
p
Hyperglycaemia Urban 76
Rural 47
p
MetSyn Urban 19
Rural 14
p
MetSyn for all residents by sex 16Diabetes Federation (IDF) and the American Heart
Association/National Heart, Lung, and Blood Institute
(AHA/NHLBI). The general principles in each definition
are similar but the cutoffs and thresholds for the variables
are somewhat different [29]. So far, the most common
used definitions in China are NCEP ATP III and IDF cri-
teria. Previous studies show that the prevalence of MetSyn
in China is already high. In an InterASIA study conducted
by Gu et al. in 2005 [12], the age-standardized prevalence
of MetSyn, defined by the modified National Cholesterol
Education Programme Adult Treatment Panel III (NCEP
ATP III), in a nationwide representative sample of adults
between 35 and 74 years of age in China was 9 · 8% for
men and 17 · 8% for women. Yang et al. found that the
prevalence of MetSyn in China was higher according to
the NCEP ATP III definition of MetSyn than according
to the IDF definition (23.3% vs 16.5%) [30]. In addition,
MetSyn prevalence was generally higher in northern China
than in southern China. A study in adult Americans aged
20 years or above by Ford et al. using the IDF definition
found the prevalence of the MetSyn was 34.5% [31], which
is higher than that in our population. Brazil and India are
the two Gold Brick Four Countries, which are considered
as having similar rapid economic development to China.
Under the NCEP ATP III definition, the prevalence of
MetSyn in India ranged from 11.0% to 32.5% [32], while in
Brazil, Marquezine reported a prevalence of 25.4% [10].metabolic syndrome based on the International Diabetes
bove by sex and urban/rural residence in 2010
Men (%) Women (%) p
.3 (3.8, 38.9) 38.2 (20.7, 55.7) < 0.001
.1 (2.0, 32.1) 38.9 (0.0, 87.9) < 0.001
0.42 0.95
.0 (52.6, 69.3) 46.5 (44.4, 48.6) < 0.001
.9 (49.7, 66.1) 45.2 (36.0, 54.4) < 0.001
0.27 0.55
.5 (19.9, 35.1) 20.4 (13.5, 27.3) < 0.001
.4 (16.3, 28.4) 13.8 (9.4, 18.1) < 0.001
0.023 <0.001
.0 (40.4, 87.7) 69.0 (61.9, 76.1) 0.17
.5 (55.4, 69.5) 79.2 (78.0, 80.4) < 0.001
0.79 < 0.001
.2 (57.0, 95.4) 70.8 (58.4, 83.1) 0.009
.7 (4.7, 90.8) 42.3 (2.8, 81.8) < 0.001
0.0077 0.0029
.8 (3.2, 36.3) 33.0 (16.6, 49.5) < 0.001
.1 (2.5, 25.7) 29.3 (0.0, 63.7) < 0.001
0.22 0.68
.3 (6.8, 25.8) 30.9 (9.7, 52.0) < 0.001
Table 3 Prevalence (%, 95% CI) for metabolic syndrome among adults aged 20 years or above by age, sex and urban/
rural residence in southern China in 2010
Total
(n = 3,561)
Age (years) p for
trend20–39 (n = 812) 40–59 (n = 1,911) 60– (n = 838)
All regions
Men 16.3 (6.8, 25.8) 12.0 (0.0, 26.0) 17.0 (12.7, 21.2) 18.5 (2.8, 34.2) <0.001
Women 30.9 (9.7, 52.0) 20.4 (5.0, 35.8) 32.6 (12.3, 52.8) 38.0 (12.6, 63.4) <0.001
Total 24.5 (8.9, 40.1) 16.9 (2.9, 30.9) 25.9 (13.9, 37.9) 28.6 (9.0, 48.2) <0.001
Urban
Men 19.8 (3.2, 36.3) 18.3 (0.0, 41.6) 19.8 (9.4, 30.2) 20.7 (0.0, 44.7) < 0.001
Women 33.0 (16.6, 49.5) 20.7 (10.7, 30.7) 33.7 (13.4, 54.0) 42.9 (0.0, 92.5) 0.099
Sub-total 27.5 (11.2, 43.8) 19.7 (15.9, 23.5) 28.4 (12.6, 44.2) 31.9 (0.0, 67.7) 0.094
Rural
Men 14.1 (2.5, 25.7) 8.5 (0.0, 18.0) 15.2 (14.8, 15.6) 16.9 (0.0, 40.4) < 0.001
Women 29.3 (0.0, 63.7) 20.3 (0.0, 43.4) 31.6 (0.0, 64.8) 34.7 (2.3, 67.02) < 0.001
Sub-total 22.5 (0.0, 46.2) 15.4 (0.0, 34.6) 24.2 (6.4, 41.9) 26.2 (0.1, 52.4) < 0.001
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MetSyn in different populations, longitudinal comparisons
can provide information for understanding the effects of
driving forces, for setting intervention priorities and for
evaluating community programs. In our study, we found
that the crude prevalence of MetSyn increased sharply
from 7.3% in 2002 to 24.5% in 2010, which means that
17.2% of normal adults developed MetSyn during an eight-
year period [19]. One major factor driving this dramatic
MetSyn escalation was likely the aging of the population as
aging is closely related to MetSyn; the mean age increased
from 44.9 in 2002 to 50.4 in 2010 [19]. The aging was more
apparent in rural areas than in urban areas. In 2002, the
urban residents were significantly older than the rural resi-
dents [19], but the difference narrowed in 2010 and was no
longer statistically significant. The steeper aging trend in
rural areas may be attributable to many young people mi-
grating from rural areas to cities in search of a better life.
This hypothesis is also in line with the higher increases we
found in the prevalence of MetSyn and its components
among rural residents than among urban residents.Table 4 Comparison between 2002 and 2010 of the
age-standardized prevalence (%, 95% CI) for the metabolic
syndrome among adults 20 years of age or above in
southern China
Survey 2002 Survey 2010
Central obesity 13.5 (10.6, 16.5) 25.4 (18.1, 32.7)
Hypertension 23.6 (20.9, 26.4) 40.8 (38.7, 42.9)
Hypertriglyceridaemia 12.1 (9.4, 14.8) 17.4 (12.6, 22.2)
Low HDL-cholesterol 32.1 (27.4, 36.8) 71.1 (65.1, 77.1)
Hyperglycaemia 9.1 (6.9, 11.3) 53.1 (38.4, 67.8)
MetSyn 5.4 (4.3, 6.5) 21.3 (15.1, 24.5)Albeit that aging was a main driver of the dramatic
escalation in MetSyn and vascular risk in this population, it
should not be the greatest contributor. In fact, the preva-
lence of MetSyn and its components increased dramatically
after controlling for age (Table 4). We speculated that rapid
industrialization and urbanization may be the most import-
ant cause of the accelerating increase in MetSyn prevalence
in this population. Between the 1940s and the late 1970s,
the major challenge faced by Chinese authorities was to
provide the people with sufficient food to meet their basic
energy and nutritional requirements [33,34]. However, since
1979, when China began to open up and reform its econ-
omy, it has enjoyed the most rapid economic development
in the world. Guangdong is the first province where the
Chinese leader Deng Xiao Ping started economic reforms
and its GDP growth has been the fastest among all the
provinces and autonomous regions of China during the
past three decades. Statistics show that Guangdong’s GDP
growth increased from RMB 410 in 1979 to RMB 44 736 in
2010 [18]. There were no data on food consumption for
Survey 2010. However, the three nutrition surveys have also
shown that the consumption of animal products increased
three folds from 1982 to 2002 in Guangdong [18]. This
rapid economic development and urbanization has increas-
ingly promoted a sedentary lifestyle, an elevated consump-
tion of energy-dense foods, and greater psychological stress,
all of which increase the risk of vascular disease [11,35].
Our results also show a greater increase from 2002 to
2010 in the prevalence of MetSyn and all its components
(except hyperglycaemia) in rural residents than in urban
residents. This means that the gap between urban and rural
residents narrowed during the eight-year period. This result
implies rapid economic development and urbanization
had a greater impact on the prevalence of MetSyn and
Lao et al. BMC Public Health 2014, 14:983 Page 6 of 7
http://www.biomedcentral.com/1471-2458/14/983its components in rural residents, who generally have
lower education levels and poorer access to health care
than urban residents. This result is also in line with the
Epidemiologic Transition theory, which predicts that in
the early stages of a country’s economic development,
chronic disease will generally be most apparent among
the most educated and wealthiest members of the popula-
tion; however, this trend will slow over time or even re-
verse as people realize the health hazards of a poor diet
and poor lifestyle choices. In the mean time, the chronic
disease burden shifts quickly to the people with lower
socio-economic status.
Information on trends in MetSyn prevalence is relatively
limited worldwide. Mozumdar et al. reported that the
prevalence increased from 27.9% to 34.1% during a period
of around a decade in U.S. adults [36]. Lim et al. reported
that MetSyn prevalence in Korea increased from 24.9% to
31.3% between 1998 and 2007 in adults aged 20 years or
over [37]. In comparison with the prevalence in 2002 [37],
our results show a jump of 17.2% in MetSyn prevalence,
as well as dramatic increases in its components, during an
eight-year period in this population. Many previous stud-
ies show increase in the individual components and other
vascular risk factors in other populations over the last
several decades [38], but progress is much slower and
the magnitudes are smaller. The more alarming results
in this population are likely related to its much more rapid
economic development and urbanization, which in turn
has led to accelerating changes in nutrition, lifestyle, and
socio-economic status. Previously published reports of our
research also note a jump in diabetes and a slight increase
in hypertension during the eight-year period [20,21]. These
findings suggest that the shifts in health and disease
patterns accompanying an epidemiologic transition in
populations with rapid economic development may be
much faster than previously observed in Western countries
[39]. The United Nations reported that around 5.7 billion
(82.2%) of the world’s population live in less developed
countries [40], where a booming economy is the top prior-
ity. Because the contemporary pace of industrialization and
urbanization is much faster, the need to instigate compre-
hensive and rigorous prevention strategies for vascular dis-
ease in these developing countries is imperative.
Conclusions
Our results show that cardiovascular risk escalated dra-
matically between 2002 and 2010 in this population ex-
periencing the world’s fastest GDP growth in last three
decades. The escalation may relate to the rapid economic
development, which led to accelerating changes in nutrition,
lifestyle, and socio-economic status. Our findings suggest
that because the contemporary pace of industrialization and
urbanization is much faster, the health transition nowadays
among the developing second- and third-world countriesmay be much faster than what has been observed in Western
countries.
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